Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
AUTOR(ES)
Kitces, E N
RESUMO
The effect of immunization with inactivated herpes virus vaccines, including a vaccine free of all nucleic acid, was investigated in a mouse model system. Protection against oral lesions induced by herpes simplex virus type 1 was demonstrated by several criteria: (i) reduction in the incidence and severity of primary oral lesions; (ii) decrease in acute and latent infection of the regional sensory ganglia; and (iii) protection from viral encephalitis and death. The immune response of mice to the vaccine and to subsequent virus challenge was measured by following serum-neutralizing antibody titers.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=421057Documentos Relacionados
- Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.
- Experimental Yersinia infection of human synovial cells: persistence of live bacteria and generation of bacterial antigen deposits including "ghosts," nucleic acid-free bacterial rods.
- Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin.
- Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet
- Appel Reaction of Carboxylic Acids with Tribromoisocyanuric Acid/Triphenylphosphine: a Mild and Acid-Free Preparation of Esters and Amides